Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Ban

Showing results (111-120 of 362) with videos related to

Pageof 37
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 1, 1984
The psychopharmacological treatment of depression in the medically ill patientT A Ban, W Guy, W H Wilson
Neuropsychobiology|January 1, 1983
Organizing and conducting clinical trialsT A Ban, W Guy, W H Wilson
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
An international survey of tardive dyskinesiaW Guy, T A Ban, W H Wilson
Wiener Klinische Wochenschrift|February 4, 1977
[The action of silymarin on Galactosamine-induced hepatitis in the rat (author's transl)]F Barbarino, A Suciu, C Cotutiu, et al.
Psychopharmacology Communications|January 1, 1975
Ascorbic acid levels in chronic psychotic patientsP Clement, T A Ban, H E Lehmann
Biochemistry|November 21, 2001
The C-terminal tail of the dual-specificity Cdc25B phosphatase mediates modular substrate recognitionM Wilborn, S Free, A Ban, et al.
Psychopharmacology Bulletin|July 1, 1977
An uncontrolled clinical study with clomacran in newly admitted schizophrenic patientsA Torres-Ruiz, D Nieto, T A Ban
International Pharmacopsychiatry|January 1, 1978
A review of nicotinic acid, N-methylated indoleamines and schizophreniaD Luchins, T A Ban, H E Lehmann
Canadian Medical Association Journal|March 24, 2010
Dose equivalent for haloperidol and phenothiazinesM Amin, H E Lehmann, T A Ban
Medicina Interna|June 1, 1972
[Clinical, biological and morphological comparisons in study of the evolutive possibilities of chronic hepatitis]O Fodor, A Ban, G Nicoară, et al.
Pageof 37

Showing results (111-120 of 362) with videos related to

Sort By:
Pageof 37
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|October 1, 1984
The psychopharmacological treatment of depression in the medically ill patientT A Ban, W Guy, W H Wilson
Neuropsychobiology|January 1, 1983
Organizing and conducting clinical trialsT A Ban, W Guy, W H Wilson
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1985
An international survey of tardive dyskinesiaW Guy, T A Ban, W H Wilson
Wiener Klinische Wochenschrift|February 4, 1977
[The action of silymarin on Galactosamine-induced hepatitis in the rat (author's transl)]F Barbarino, A Suciu, C Cotutiu, et al.
Psychopharmacology Communications|January 1, 1975
Ascorbic acid levels in chronic psychotic patientsP Clement, T A Ban, H E Lehmann
Biochemistry|November 21, 2001
The C-terminal tail of the dual-specificity Cdc25B phosphatase mediates modular substrate recognitionM Wilborn, S Free, A Ban, et al.
Psychopharmacology Bulletin|July 1, 1977
An uncontrolled clinical study with clomacran in newly admitted schizophrenic patientsA Torres-Ruiz, D Nieto, T A Ban
International Pharmacopsychiatry|January 1, 1978
A review of nicotinic acid, N-methylated indoleamines and schizophreniaD Luchins, T A Ban, H E Lehmann
Canadian Medical Association Journal|March 24, 2010
Dose equivalent for haloperidol and phenothiazinesM Amin, H E Lehmann, T A Ban
Medicina Interna|June 1, 1972
[Clinical, biological and morphological comparisons in study of the evolutive possibilities of chronic hepatitis]O Fodor, A Ban, G Nicoară, et al.
Pageof 37